The Swiss TAVI registry is supported by a study grant from the Swiss Heart Foundation and the Swiss Working Group of Interventional Cardiology, and is sponsored by funds from Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and Guerbet AG.

The sponsors have no role in study design, data collection, data analysis, data interpretation, or writing of reports.